Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nadia Rokan, Deepika Reddy
Format: Artículo Open Access
Veröffentlicht: Wiley 2025
Schlagworte:
Online-Zugang:https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.70000
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867006313062465536
author Nadia Rokan
Deepika Reddy
author_facet Nadia Rokan
Deepika Reddy
Nadia Rokan
Deepika Reddy
collection Wiley Open Access
contents Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom Nadia Rokan Deepika Reddy BJUI Compass AbstractProstate cancer is a significant health issue in the United Kingdom, with rising incidence rates prompting the exploration of innovative treatment options. Focal therapy has emerged as a targeted approach that aims to treat localised prostate cancer while minimising damage to surrounding healthy tissue and subsequent adverse side effects. Focal therapy is National Institute for Health and Care Excellence (NICE)‐approved treatment modality for patients with intermediate‐risk localised prostate cancer. This is an evolving field, reflecting the rapidly improved understanding of both the trajectory patients face following a diagnosis of prostate cancer, and how best to apply ablative techniques.In this narrative review, we evaluate the historical development, current practices, clinical outcome reported in UK‐based studies, and future directions of focal therapy for prostate cancer in the United Kingdom, highlighting its evolution as a viable treatment option. 10.1002/bco2.70000 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/bco2.70000
format Artículo Open Access
id wiley_oa_10_1002_bco2_70000
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
Nadia Rokan
Deepika Reddy
BJUI Compass
Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom Nadia Rokan Deepika Reddy BJUI Compass AbstractProstate cancer is a significant health issue in the United Kingdom, with rising incidence rates prompting the exploration of innovative treatment options. Focal therapy has emerged as a targeted approach that aims to treat localised prostate cancer while minimising damage to surrounding healthy tissue and subsequent adverse side effects. Focal therapy is National Institute for Health and Care Excellence (NICE)‐approved treatment modality for patients with intermediate‐risk localised prostate cancer. This is an evolving field, reflecting the rapidly improved understanding of both the trajectory patients face following a diagnosis of prostate cancer, and how best to apply ablative techniques.In this narrative review, we evaluate the historical development, current practices, clinical outcome reported in UK‐based studies, and future directions of focal therapy for prostate cancer in the United Kingdom, highlighting its evolution as a viable treatment option. 10.1002/bco2.70000 http://creativecommons.org/licenses/by/4.0/
title Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
topic BJUI Compass
url https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.70000